Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pfizer, Mylan Settle on Generic Effexor XR | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Pfizer, Mylan Settle on Generic Effexor XR

Mylan to sell generic Effexor XR in mid-2011

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Mylan Pharmaceuticals Inc. has entered into settlement and license agreement with Pfizer, relating to Venlafaxine Hydrochloride (HCl) Extended Release (ER) Capsules, 37.5 mg, 75 mg and 150 mg, the generic version ofEffexor XR Capsules, a treatment for major depressive disorder. The drug is marketed by Wyeth, which was acquired by Pfizer earlier this year.

Mylan will be granted a non-exclusive license to the relevant patents that would permit Mylan to launch generic Venlafaxine HCl ER Capsules in the U.S. on or after June 1, 2011, “or earlier in limited circumstances,” according to a Mylan statement. Further details of the agreement remain confidential.

Effexor XR had U.S. sales of approximately $2.9 billion for those dosage strengths for the 12 months ending Sept. 30, according to IMS Health.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics